All News

The advent of personalised medicine means cancer survival over the long term could be improved by running smaller, faster trials with less stringent evidence criteria, the 2011 European Multidisciplinary Cancer Congress in Sweden heard this week

The funds will be used to finance the SARCOB project, which is aimed at improving the nutrition of the elderly and at preventing and treating sarcopenic obesity with natural substances

The consumer goods company gets access to all resources through a single agreement

European research giant Fraunhofer to work with Western on developing and processing composite materials for lightweight vehicles

Uppsala BIO cluster is to become the ninth member of the Swiss pharma’s global network for early-stage research

£3M project to support the future design, operation and roll-out of cost effective carbon capture and storage systems

In a ceremony with less media fanfare than US patent attorneys might have expected, President Obama signed into law legislation that radically revises US patent law.

A new treatment for prostate cancer launched in the UK this week. The drug was discovered by scientists in London, funded by the public. So why is it owned by a US pharma giant?